Jefferies Downgrades Sanofi (SNY) to Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends up on Iran war peace deal hopes, SpaceX's historic debut
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
BofA/Merrill Lynch Downgrades Sanofi-Aventis (SNY) to Neutral on CEO Removal
October 29, 2014 8:47 AM EDTBofA/Merrill Lynch downgraded Sanofi-Aventis (NYSE: SNY) from Buy to Neutral with a price target of $48.00 after the announcement that it has unanimously voted to remove Chris Viehbacher from his position as CEO.
Analyst Graham Parry said the news is negative for several... More
Barclays Downgrades Sanofi (SNY) to Equalweight
October 29, 2014 8:35 AM EDTBarclays downgraded Sanofi (NYSE: SNY) from Overweight to Equalweight.
For an analyst ratings summary and ratings history on Sanofi click here. For more ratings news on Sanofi click here.
Shares of Sanofi closed at $48.07 yesterday.
... MoreDeutsche Bank Downgrades Sanofi (SNY) to Hold
October 29, 2014 8:34 AM EDTDeutsche Bank downgraded Sanofi (NYSE: SNY) from Buy to Hold with a price target of EUR 78 from EUR 93.
Analyst Mark Clark said, "We have been BUYers of Sanofi since we initiated coverage in 2009 but now feel it is time to... More
Sanofi (SNY) Terminates CEO Viehbacher
October 29, 2014 6:00 AM EDTThe Board of Directors held a meeting Wednesday, October 29 at 8am and decided unanimously to remove Christopher A. Viehbacher as Chief Executive Officer of Sanofi (NYSE: SNY). As a consequence Christopher A. Viehbacher resigned as a director of Sanofi.
The Board of... More
